Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,169.9
9.2 (0.29%)

 

  • STI Straits Times Index
    3,169.9
    9.2 (0.29%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,598.3
    -3.5 (-0.22%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    27,353.9
    86.8 (0.32%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,853.0
    0.5 (0.02%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,117.2
    -33.9 (-0.16%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,057.4
    24.7 (0.41%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,045.3
    -14.3 (-0.69%)
    Index delayed 20 minutes
  • XAO XAO
    6,545.6
    -38.7 (-0.59%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 695.3M
  • Value: 914.3M
  • Rise: 177
  • Fall: 116
  • Unch: 548

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
YZJ Shipbldg SGD1.370-0.010
ISR Capital^0.002-
Golden Agri-Res0.265-0.010
AA0.010-0.003
Eagle HTrust USD0.730-
Genting Sing0.870-0.005
CapitaCom Trust1.920-
Asian Pay Tv Tr0.177+0.004
Rex Intl0.063+0.001
SingTel3.150+0.030

World Indices

World Indices
Name Last Change
Nasdaq 7,628.3 -122.6
HSI 27,353.9 +86.8
HSCEI 10,445.5 +44.4
Jakarta 6,057.4 +24.7
Nikkei 225 21,117.2 -33.9
SSE Comp 2,853.0 +0.5
Shanghai A 2,988.1 +0.6
Shanghai B 285.8 -2.1
ShenZhen A 1,564.5 -7.7
ShenZhen B 931.3 -1.4
Taiwan W 10,328.3 +19.9
PSE Comp 0.0
KOSPI 2,045.3 -14.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Biolidics BIOLIDICS LIMITED
Quotes 10 Minutes Delayed. Updated at 24 May 2019 15:59
Last (SGD): 0.290 Change: - High: - Remarks: -
Change (%): - Low: -
Open - Yesterday's Close 0.290
Buy Price 0.280 Sell Price 0.300
Buy Volume ('000) 9.0 Sell Volume ('000) 9.9
Cumulative Volume ('000) - Cumulative Value -
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a -0.02578 Trailing EPS (SGD) e -0.02578 NAV (SGD) b 0.0518
PE a - Trailing PE f - Price / NAV b 5.5985
Dividend (SGD) d - Cash In Hand (SGD) g 0.0474 Issued & Paid-up Shares c 242,500,000
Dividend Yield (%) d - Price / Cash In Hand g 6.118 Treasury Shares h -
Beta - 75 Daysi 2.104 R-Squared - 75 Days(%)i 12.36 Market Cap (M) 70.325
Beta - 500 Daysi 1.847 R-Squared - 500 Days (%)i 8.96 Enterprise Value (M) 58.826
Piotroski F Score - Exchange Code 8YY Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 6-Month VWAP n.a. Free Float (%) 99.7
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Service - Medical Specialties
Category Classification Medical & Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 15 Apr 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Biolidics SGX 70.325 - - 5.5985 -
Industry Medical & Biotechnology SGX 994.909 22.755 19.857 1.0965 1.893
Medical Specialties SGX 731.413 34.569 34.999 4.2896 1.666
Local Peer Top Glove SGX 4,224.960 29.261 29.365 5.1163 1.720
Local Peer UG Healthcare SGX 36.340 8.382 11.029 0.8430 1.238
Local Peer Yunnan Energy SGX 26.442 - - 0.5069 -
Local Peer Annica SGX 16.675 - - 3.3333 -
Local Peer Medtecs Intl SGX 13.735 11.013 11.015 0.1615 -
Global Peer ABBOTT LABORATORIES NYSE 133,424.933 56.704 51.219 4.3145 1.526
Global Peer MEDTRONIC PLC NYSE 122,861.748 39.582 24.977 2.4657 2.116
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 108,402.851 36.897 34.153 3.9144 0.271
Global Peer DANAHER CORP NYSE 94,238.392 35.550 39.077 3.1458 0.476
Global Peer STRYKER CORP NYSE 68,837.872 19.375 19.545 5.8871 1.050
Global Peer BECTON DICKINSON & CO NYSE 63,117.288 396.967 68.088 2.9623 1.283
Global Peer INTUITIVE SURGICAL INC NASDAQ 54,697.427 48.495 47.696 7.7870 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 52,552.664 31.450 29.245 5.6919 -
Global Peer BAXTER INTERNATIONAL INC NYSE 38,277.905 23.570 24.196 5.0063 0.978
Global Peer EDWARDS LIFESCIENCES CORP NYSE 35,439.085 49.071 46.307 10.2797 -
Other Global Peers ALIGN TECHNOLOGY INC (NASDAQ), ZIMMER BIOMET HOLDINGS INC (NYSE), IDEXX LABORATORIES INC (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), RESMED INC (NYSE), COOPER COS INC (NYSE), WATERS CORP (NYSE), TELEFLEX INC (NYSE), DENTSPLY SIRONA INC (NASDAQ), HOLOGIC INC (NASDAQ), ABIOMED INC (NASDAQ), VARIAN MEDICAL SYSTEMS INC (NYSE), STERIS PLC (NYSE), DEXCOM INC (NASDAQ), PERKINELMER INC (NYSE), BIO RAD LABORATORIES INC (NYSE), QIAGEN NV (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COCHLEAR LTD (ASX), MASIMO CORPORATION (NASDAQ), BRUKER CORPORATION (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), INSULET CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), HAEMONETICS CORP (NYSE), NOVOCURE LTD (NASDAQ), PENUMBRA INC (NYSE), ICU MEDICAL INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), HARTA (Bursa), GLOBUS MED INC (NYSE), WEIGAO GROUP (HKEx), WRIGHT MEDICAL GROUP NV (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), LIVANOVA PLC (NASDAQ), NUVASIVE INC (NASDAQ), TOPGLOV (Bursa), NEOGEN CORP (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), CANTEL MEDICAL CORP (NYSE), GLAUKOS CORPORATION (NYSE), EBOS GROUP (ASX), CONMED CORP (NASDAQ), QUIDEL CORP (NASDAQ), AVANOS MEDICAL INC (NYSE), NEVRO CORP (NYSE), ATRION CORP (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), INOGEN INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), CAREDX INC (NASDAQ), MICROPORT (HKEx), INSPIRE MEDICAL SYSTEMS INC (NYSE), ATRICURE INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), CRYOLIFE INC (NYSE), VAREX IMAGING CORPORATION (NASDAQ), MESA LABORATORIES INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), NANOSONICS LIMITED (ASX), LEMAITRE VASCULAR INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), VIEWRAY INC (NASDAQ), AXOGEN INC (NASDAQ), CIRC (HKEx), LIFETECH SCI (HKEx), ANGIODYNAMICS INC (NASDAQ), CERUS CORP (NASDAQ), VERICEL CORP (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), QUOTIENT LTD (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), HESKA CORP (NASDAQ), SURMODICS INC (NASDAQ), YESTAR HEALTH (HKEx), SUPERMX (Bursa), ORASURE TECHNOLOGIES INC (NASDAQ), CORINDUS VASCULAR ROBOTICS INC (NYSE American), ESTABLISHMENT LABS HLDGS INC (NASDAQ), AK MEDICAL (HKEx), ANTARES PHARMA INC (NASDAQ), CORMEDIX INC (NYSE American), MCP INCOME OPPORTUNITIES TRUST (ASX), SI BONE INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), AVEDRO INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), VAPOTHERM INC (NYSE), GOLDEN MEDITECH (HKEx), ROCKWELL MEDICAL INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), NEURONETICS INC (NASDAQ), CUTERA INC (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), PULSE BIOSCIENCES INC (NASDAQ), IRADIMED CORP (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), ZYNEX INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), PW MEDTECH (HKEx), CONFORMIS INC (NASDAQ), INVACARE CORP (NYSE), INTRICOM CORP (NASDAQ), CYTOSORBENTS CORP (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), CRH MEDICAL CORP (NYSE American), AVID BIOSERVICES INC (NASDAQ), MISONIX INC (NASDAQ), SIENTRA INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), MODERN DENTAL (HKEx), ONCOCYTE CORP (NYSE American), BIOSIG TECHNOLOGIES INC (NASDAQ), FONAR CORP (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), BIOTIME INC (NYSE American), CHEMBIO DIAGNOSTICS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), ENDOLOGIX INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), NEUROTROPE INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), YUNNAN ENERGY (HKEx), SOLITON INC (NASDAQ), ELECTROCORE INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), SOMNOMED LIMITED (ASX), SDI LTD (ASX), MOTUS GI HOLDINGS INC (NASDAQ), IRIDEX CORP (NASDAQ), COMPUMEDICS (ASX), NUVECTRA CORPORATION (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), CYCLOPHARM LIMITED (ASX), ELLEX MEDICAL LASERS LTD (ASX), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), VINCENT MED (HKEx), ALPHA PRO TECH (NYSE American), RESPIRI LTD (ASX), RA MEDICAL SYSTEMS INC (NYSE), IMPEDIMED LIMITED (ASX), ZOSANO PHARMA CORP (NASDAQ), ELECTROMED INC (NYSE American), IMMUCELL CORP (NASDAQ), CELSION CORPORATION (NASDAQ), BIOLASE INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), PAVMED INC (NASDAQ), RESONANCE HEALTH LTD (ASX), DAXOR CORP (NYSE American), AVINGER INC (NASDAQ), MICRO-X LTD (ASX), VIVEVE MEDICAL INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), NEOVASC INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), ADMEDUS LTD (ASX), ATOSSA GENETICS INC (NASDAQ), INSPIREMD INC (NYSE American), BIOMERICA INC (NASDAQ), RESTORATION ROBOTICS INC (NASDAQ), LBT INNOVATIONS LTD (ASX), LIFE HEALTHCARE (HKEx), DARIOHEALTH CORP (NASDAQ), OBJ LIMITED (ASX), RETRACTABLE TECHNOLOGIES INC (NYSE American), CHECK-CAP LTD (NASDAQ), OVENTUS MEDICAL LTD (ASX), CYANOTECH CORP (NASDAQ), CARDIEX LTD (ASX), PRECISION THERAPEUTICS INC (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), OBALON THERAPEUTICS INC (NASDAQ), USCOM LTD (ASX), ADVENTA (Bursa), HUAKANG BIOMED (HKEx), COMBEST HOLD (HKEx), DYNATRONICS CORP (NASDAQ), DIGIRAD CORP (NASDAQ), REALM THERAPEUTICS PLC SPONSORED ADS (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), VALERITAS HOLDINGS INC (NASDAQ), OPTISCAN IMAGING (ASX), ANALYTICA (ASX), LKL (Bursa), MILESTONE SCIENTIFIC INC (NYSE American), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), DIMERIX LTD (ASX), IMPRESSION HEALTHCARE LIMITED (ASX), AKERS BIOSCIENCES INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), MICRON SOLUTIONS INC (NYSE American), ALLEGRA ORTHOPAEDICS LIMITED (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), AETHLON MEDICAL (NASDAQ), CESCA THERAPEUTICS INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), NEUROMETRIX INC (NASDAQ), CH DEMETER FIN (HKEx), METALICITY LIMITED (ASX), ADHERIUM LIMITED (ASX), SINTX TECHNOLOGIES INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), MY MEDICARE (HKEx), STHAI (SET), MEDIGARD LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days -+0.010
+3.57 %
20 Days --0.010
-3.33 %
Medium Term Return 3 Months -+0.015
+5.45 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.180 - 0.330 Change From 1 Year Low +0.110 % Change From 1 Year Low (%) +61.11
Change From 1 Year High -0.040 % Change From 1 Year High (%) -12.12
2 Years Range 0.180 - 0.330 Change From 2 Years Low +0.110 % Change From 2 Years Low (%) +61.11
Change From 2 Years High -0.040 % Change From 2 Years High (%) -12.12
5 Years Range 0.180 - 0.330 Change From 5 Years Low +0.110 % Change From 5 Years Low (%) +61.11
Change From 5 Years High -0.040 % Change From 5 Years High (%) -12.12
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Company is a Singapore-based medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring. The Company aspires to impact the lives of patients through the provision of diagnostic solutions in every cancer centre worldwide. The Company has developed the ClearCell FX1 System, a fully automated IVD medical device which relies on a novel patented technology to separate and enrich cancer cells from blood. This allows users of the system to perform liquid biopsies to test for the presence of cancer cells (specifically circulating tumour cells, or CTCs) in blood samples or perform further analysis on cancer cells, providing a simple and minimally invasive alternative to tissue biopsies, which involve the surgical removal of tissue from a patients body.

IPO Performance

Listing Date 19 Dec 2018 Full Subscription Rate (x) -
No of Placement Shares (M) 27.50 No of Public Offer Shares (M) - Public Offer Subscription Rate (x) -
IPO Price (SGD) 0.280 First Day Close (SGD) 0.235 First Week Close (SGD) 0.230
Current vs IPO Price (%) +3.57 First Day Gain (%) -16.07 First Week Gain (%) -17.86

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2018 Dec 2018 Part 1(3.41 MB)
IPO Prospectus
IPO Prospectus 2018 Dec 2018 Part 1(2.88 MB)
Part 2(0.53 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
24 May 2019 0.290 0.290 0.290 0.290 - -
23 May 2019 0.290 0.290 0.290 0.290 - -
22 May 2019 0.290 0.290 0.290 0.290 - -
21 May 2019 0.290 0.290 0.290 0.290 - -
17 May 2019 0.280 0.290 0.280 0.290 23,800 0.2816
16 May 2019 0.295 0.295 0.295 0.295 - -
15 May 2019 0.275 0.295 0.270 0.295 76,000 0.2747
14 May 2019 0.285 0.285 0.285 0.285 - -
13 May 2019 0.275 0.290 0.275 0.285 30,000 0.2784
10 May 2019 0.290 0.290 0.280 0.280 10,100 0.2850
09 May 2019 0.280 0.290 0.280 0.285 38,700 0.2825
08 May 2019 0.280 0.280 0.280 0.280 20,000 0.2800
07 May 2019 0.280 0.290 0.280 0.290 7,000 0.2811
06 May 2019 0.280 0.290 0.265 0.270 225,300 0.2732
03 May 2019 0.290 0.300 0.285 0.300 109,000 0.2873
02 May 2019 0.300 0.300 0.300 0.300 - -
30 Apr 2019 0.290 0.300 0.290 0.300 10,200 0.2902
29 Apr 2019 0.300 0.300 0.300 0.300 - -
26 Apr 2019 0.300 0.300 0.300 0.300 - -
25 Apr 2019 0.290 0.300 0.290 0.300 80,500 0.2901
24 Apr 2019 0.295 0.295 0.295 0.295 15,000 0.2950
23 Apr 2019 0.295 0.310 0.295 0.300 570,400 0.2982
Summary
Current 2 Weeks
(10 May 2019 to 24 May 2019)
0.290 0.295 0.270 0.290 139,900 -
Previous 2 Weeks
(25 Apr 2019 to 09 May 2019)
0.290 0.300 0.270 0.285 490,700 -
4 Weeks from
(27 Mar 2019 to 24 Apr 2019)
0.270 0.295 0.260 0.295 6,366,000 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.